Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Grail Inc (GRAL)

Grail Inc (GRAL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,798,405
  • Shares Outstanding, K 38,982
  • Annual Sales, $ 125,600 K
  • Annual Income, $ -2,027 M
  • EBIT $ -547 M
  • EBITDA $ 1,029 M
  • 60-Month Beta 4.52
  • Price/Sales 24.02
  • Price/Cash Flow 3.63
  • Price/Book 1.69

Options Overview Details

View History
  • Implied Volatility 80.20% (-4.32%)
  • Historical Volatility 59.87%
  • IV Percentile 11%
  • IV Rank 15.90%
  • IV High 161.34% on 02/14/25
  • IV Low 64.86% on 01/21/25
  • Expected Move (DTE 35) 15.81 (16.35%)
  • Put/Call Vol Ratio 1.13
  • Today's Volume 2,454
  • Volume Avg (30-Day) 1,431
  • Put/Call OI Ratio 0.57
  • Today's Open Interest 41,342
  • Open Int (30-Day) 36,562
  • Expected Range 80.89 to 112.51

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -3.33
  • Number of Estimates 1
  • High Estimate -3.33
  • Low Estimate -3.33
  • Prior Year -1.86
  • Growth Rate Est. (year over year) -79.03%

Price Performance

See More
Period Period Low Period High Performance
1-Month
84.08 +15.01%
on 12/31/25
108.93 -11.23%
on 01/12/26
+9.68 (+11.12%)
since 12/16/25
3-Month
74.00 +30.68%
on 11/07/25
115.76 -16.47%
on 11/25/25
+10.29 (+11.91%)
since 10/16/25
52-Week
17.12 +464.84%
on 01/17/25
115.76 -16.47%
on 11/25/25
+79.29 (+455.59%)
since 01/16/25

Most Recent Stories

More News
Small-Cap Standouts: These 3 Stocks Rose Over 300% in 2025

These three stocks started 2025 small, but graduated to mid-cap territory after +300% gains. See what caused their rise, and what analysts are forecasting.

GRAL : 96.70 (-0.76%)
VSAT : 45.94 (+4.15%)
PL : 28.78 (+1.77%)
ASTS : 115.77 (+14.34%)
GRAIL to Present at the 44th Annual J.P. Morgan Healthcare Conference

MENLO PARK, Calif. , Dec. 15, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management...

GRAL : 96.70 (-0.76%)
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

MENLO PARK, Calif. , Dec. 1, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that it has granted...

GRAL : 96.70 (-0.76%)
Why GRAIL Stock Could Be Biotech’s Next Big Breakout

Explore insider buying signals, a promising cancer detection biotech, and why the American Dream is still achievable—even in a down market.

GRAL : 96.70 (-0.76%)
MRK : 108.83 (-1.93%)
JNJ : 218.66 (-0.41%)
PFE : 25.65 (-0.93%)
BMY : 55.26 (-2.40%)
GRAIL to Present at Piper Sandler 37th Annual Healthcare Conference

MENLO PARK, Calif. , Nov. 18, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management...

GRAL : 96.70 (-0.76%)
GRAIL Reports Third Quarter 2025 Financial Results

Q3 U.S. Galleri Revenue Grew 28% Year-Over-Year to $32.6 Million

GRAL : 96.70 (-0.76%)
GRAIL to Present at 7th Annual Wolfe Research Healthcare Conference

MENLO PARK, Calif. , Nov. 4, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management...

GRAL : 96.70 (-0.76%)
GRAIL to Announce Third Quarter 2025 Financial Results

Analyst Day 2025 Webcast to Begin at 11:00 a.m. ET on November 13 th

GRAL : 96.70 (-0.76%)
GRAIL, Inc. Announces $325.0 Million Private Placement Financing

MENLO PARK, Calif. , Oct. 20, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that it has entered...

GRAL : 96.70 (-0.76%)
GRAIL and University of Oxford to Present Long-Term Data From the SYMPLIFY Study Evaluating the Galleri® Multi-Cancer Early Detection Test in Symptomatic Individuals at the Early Detection of Cancer Conference (EDCC)

One-Third of Participants Initially Believed to Have a False-Positive Result Were Later Diagnosed With Cancer During Follow Up

GRAL : 96.70 (-0.76%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

GRAIL LLC is a biotechnology company. It focuses on developing technologies for early cancer detection. GRAIL LLC is based in Menlo Park, United States.

See More

Key Turning Points

3rd Resistance Point 105.44
2nd Resistance Point 103.07
1st Resistance Point 99.88
Last Price 96.70
1st Support Level 94.32
2nd Support Level 91.95
3rd Support Level 88.76

See More

52-Week High 115.76
Last Price 96.70
Fibonacci 61.8% 78.08
Fibonacci 50% 66.44
Fibonacci 38.2% 54.80
52-Week Low 17.12

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar